← Leaderboards
Robert M Clancy
Hospital For Joint Diseases Ortho Inst
$3,179,563
Attributed
$3,179,563
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $398K · FY2005–21$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,179,563 · 5
By mechanism
P50$1,471,467 · 1
R01$1,456,806 · 1
R21$150,000 · 1
R55$100,000 · 1
M01$1,290 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeProductionBaseMaintenanceMolecularLupusAutoimmunitySystemic Lupus ErythematosusInjuryDeoxyribonucleasesAutoimmune ResponsesCommunitiesComplexCross ReactivityDisease ProgressionBirthAutoantigensChildCohortAllelesAutoimmune DiseasesBiomarker DiscoveryAdaptive Immune SystemBenign State
Grant awards (13)
Project 1: Profiling anti-Ro preclinical and clinical autoimmunity$346,928
P50 · FY2021 · AR · contact PI
Project 1: Profiling anti-Ro preclinical and clinical autoimmunity$296,891
P50 · FY2020 · AR · contact PI
Project 1: Profiling anti-Ro preclinical and clinical autoimmunity$268,063
P50 · FY2019 · AR · contact PI
Project 1: Profiling anti-Ro preclinical and clinical autoimmunity$272,840
P50 · FY2018 · AR · contact PI
Project 1: Profiling anti-Ro preclinical and clinical autoimmunity$286,745
P50 · FY2017 · AR · contact PI
Endothelial reactivity and nitric oxide synthetase activity in the ALMS (Aspreva$351,101
R01 · FY2009 · AR · contact PI
Endothelial reactivity and nitric oxide synthetase activity in the ALMS (Aspreva$350,277
R01 · FY2008 · AR · contact PI
Endothelial reactivity and nitric oxide synthetase activity in the ALMS (Aspreva$357,426
R01 · FY2007 · AR · contact PI
Endothelial reactivity and nitric oxide synthetase activity in the ALMS (Aspreva$398,002
R01 · FY2006 · AR · contact PI
CHILDHOOD ABSENCE EPILEPSY RX, PK-PD-PHARMACOGENETICS$1,290
M01 · FY2005 · RR
Antibody-Induced Injury in Congenital Heart Block$100,000
R55 · FY2002 · AR
Cardiac myofibroblasts in autoimmune-associated CHB$75,000
R21 · FY2002 · AR
Cardiac myofibroblasts in autoimmune associated CHB$75,000
R21 · FY2001 · AR